---
layout: post
title: Ovarian Steroids and Neurodegenerative Diseases
subtitle: ovarian steriods and their relationship with development of neurodegenerative diseases


<img src="/img/Jennifer_JClub.jpg" alt="Jennifer: Journal Club" class="inline"/><a name="Jennifer: Journal Club"></a>

<b>Jennifer Sutton</b>, <i>Community Leader</i> of the RIPL_Effect research team, from the state of Florida, and aspiring physician with plenty of volunteering experience with the community, shared her Journal Club talk on the ovarian steriods and their relationship with development of neurodegenerative diseases. The article Jennifer presented discussed was published by <i>Bethea C.L. and Reddy A.P. </i> (2015) in the journal <i>Molecular Psychiatry</i> (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508249/" target="_blank">click here to access the article</a>). Among the authors' findings were that timely steroid hormone therapy among females could reduce the incidence of depression and neurodegenerative diseases. 

